✦ LIBER ✦

Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models

✍ Scribed by Marianne Schrader de Oliveira; Giovana Cechim; Elisandra Braganhol; Daniel Garcia Santos; Luise Meurer; Cláudio Galvão de Castro; Algemir Lunardi Brunetto; Gilberto Schwartsmann; Ana Maria Oliveira Battastini; Guido Lenz; Rafael Roesler

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 83 KB
Volume: 93
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-009-9851-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-proliferative effect of the gastrin

Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models

✍ Marianne Schrader de Oliveira; Giovana Cechim; Elisandra Braganhol; Daniel Garci 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 571 KB

Protective effect of RC-3095, an antagon

Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis

✍ P. G. Oliveira; R. Grespan; L. G. Pinto; L. Meurer; J. C. T. Brenol; R. Roesler; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

Inhibitory effect of bombesin/gastrin-re

Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone—releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice

✍ Tetsu Yano; Jacek Pinski; Karoly Szepeshazi; Gabor Halmos; Sinisa Radulovic; Kat 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 940 KB

Bombesin/gastrin-releasing peptide antag

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

✍ Miklós Koppán; Gábor Halmos; José M. Arencibia; Najib Lamharzi; Andrew V. Schall 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## BACKGROUND. Antagonists of bombesin/gastrin-releasing peptide (BN/GRP) have been developed to block the autocrine stimulatory effect of BN/GRP on tumors such as small cell lung carcinoma (SCLC). Although several studies have addressed the intracellular events that follow the formation of the re